FDA Adverse Event Malfunction Summary report: N

BATROXOBIN REAGENT

MDR report key: 20146341 · Received September 5, 2024

Report

Report Number
9610806-2024-00033
Event Type
Malfunction
Date Received
September 5, 2024
Date of Event
August 20, 2024
Report Date
September 5, 2024
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Product Code
JCO
UDI-DI
00842768011504
PMA / PMN Number
K932787
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AN OUTSIDE OF THE UNITED STATES (OUS) CUSTOMER CONTACTED THE SIEMENS REGIONAL SUPPORT CENTER (RSC) TO REPORT A FALSELY DEPRESSED BATROXOBIN TIME (BXT) RESULT ON A SYSMEX CN-6000 INSTRUMENT. PER THE LIMITATIONS SECTION OF THE BATROXOBIN INSTRUCTIONS FOR USE (IFU): "RESULTS OF THIS TEST SHOULD ALWAYS BE INTERPRETED IN CONJUNCTION WITH THE PATIENT'S MEDICAL HISTORY, CLINICAL PRESENTATION AND OTHER FINDINGS." SIEMENS EVALUATED THIS ISSUE AND PROVIDED THE FOLLOWING CONCLUSION: REAGENT ISSUES WERE RULED OUT BASED ON REVIEW OF QUALITY CONTROL (QC) RESULTS WHICH SHOWED RECOVERY WITHIN ACCEPTABLE RANGES AND NO ISSUES WERE REPORTED WITH OTHER PATIENT SAMPLES. IN ADDITION, AN ASSESSMENT OF INSTRUMENT PERFORMANCE INCLUDED A REVIEW OF BACKUP DATA FILES. BASED ON THE AVAILABLE INFORMATION, THE CAUSE OF THE DISCORDANT RESULT IS CONSISTENT WITH A SAMPLE INTEGRITY ISSUE. THE CUSTOMER IS OPERATIONAL, AND THE REPORTED ISSUE IS RESOLVED BY ROUTINE TROUBLESHOOTING. SYSMEX CN-6000 BATROXOBIN LOT 509792 IS PERFORMING AS INTENDED. A PRODUCT PERFORMANCE ISSUE HAS NOT BEEN IDENTIFIED. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED THE OBSERVATION OF A FALSELY DEPRESSED BATROXOBIN TIME (BXT) RESULT ON A SYSMEX CN-6000 SYSTEM. THE INITIAL RESULT WAS NOT REPORTED TO THE PHYSICIAN(S). THE CUSTOMER REPEATED THE TEST AND THE REPEAT RESULTS WERE HIGHER THEN THE INITIAL RESULT. THE REPEAT RESULTS WERE REPORTED, AS THE CORRECT RESULTS, TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT BATROXOBIN TIME (BXT) RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2041932 BATROXOBIN REAGENT BOTHROPS ATROX REAGENT JCO SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH N/A 509792 00842768011504

Patients

Seq Age Sex Outcome Treatment
1 29 YR Male